Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genic Co. Ltd. (123330:KRX), powered by AI.
Genic Co. Ltd. is currently trading at ₩21,950. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Genic Co. Ltd. on Alpha Lenz.
Genic Co. Ltd.'s P/E ratio is 9.3.
“Genic Co. Ltd. trades at a P/E of 9.3 (undervalued) with strong ROE of 59.8%. 3Y revenue CAGR of 35.5% highlights clear growth momentum.”
Ask for details →Genic Co. Ltd. is a company specializing in the design, development, and manufacturing of an extensive range of cosmetic products. It focuses primarily on skincare items, which include creams, lotions, serums, and other topical solutions aimed at enhancing and nourishing skin health. The company places a strong emphasis on research and innovation, utilizing cutting-edge technology and scientific advancements to produce high-quality products that cater to various skin types and conditions. Operating in the highly competitive personal care sector, Genic Co. Ltd. plays a significant role in impacting beauty trends and consumer preferences both domestically and internationally. The company is committed to sustainability and eco-friendliness, often incorporating natural ingredients and environmentally conscious practices in its production processes. As a key player in the cosmetic industry, Genic Co. Ltd. contributes to shaping the market landscape through its innovative offerings and dedication to customer satisfaction, establishing itself as a trusted name in skincare solutions.
“Genic Co. Ltd. trades at a P/E of 9.3 (undervalued) with strong ROE of 59.8%. 3Y revenue CAGR of 35.5% highlights clear growth momentum.”
Ask for details →Genic Co. Ltd. (ticker: 123330) is a company listed on KRX in the Consumer Defensive sector (Household & Personal Products). It has approximately 324 employees. Market cap is $174.9B.
The current price is ₩21,950 with a P/E ratio of 9.26x and P/B of 4.26x.
ROE is 59.77% and operating margin is 19.15%. Annual revenue is $78.2B.